'Er pgr' presentation slideshows

Edith A. Perez, MD Director, Cancer Clinical Study Unit Mayo Clinic Jacksonville, Florida

Welcome and Introductions. Edith A. Perez, MD Director, Cancer Clinical Study Unit Mayo Clinic Jacksonville, Florida. The Early Use of Adjuvant Aromatase Inhibitors for Early Breast Cancer: New Contributions from the BIG 1-98 Letrozole Trial. John F. Forbes, MB, BS, MS, FRACS

521 views • 40 slides

Edith A. Perez, MD Director, Cancer Clinical Study Unit Mayo Clinic Jacksonville, Florida

Welcome and Introductions. Edith A. Perez, MD Director, Cancer Clinical Study Unit Mayo Clinic Jacksonville, Florida. The Early Use of Adjuvant Aromatase Inhibitors for Early Breast Cancer: New Contributions from the BIG 1-98 Letrozole Trial. John F. Forbes, MB, BS, MS, FRACS

520 views • 40 slides

1. Baselga et al . N Engl J Med 2011

A Phase III, Randomized, Double-Blind, Placebo-Controlled Registration Trial to Evaluate the Efficacy and Safety of Placebo + Trastuzumab + Docetaxel vs. Pertuzumab + Trastuzumab + Docetaxel in Patients with Previously Untreated HER2-Positive Metastatic Breast Cancer (CLEOPATRA).

409 views • 23 slides

Disclosures

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of two large prospective studies. E. Amir , M. Clemons, O.C. Freedman, N. Miller, R.E. Coleman, C. Purdie, L. Jordan, P. Quinlan, A.M. Thompson. Disclosures.

318 views • 22 slides

373 views • 19 slides